![Philippe Chambon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Chambon
Director/Board Member at
BioRelix, Inc.
Profile
Philippe O.
Chambon was the founder of New Leaf Venture Partners LLC, serving as Managing Director since 2005 until 2018.
Current jobs include Director at BioRelix, Inc. since 2009, Director at Qpid Health, Inc. since 2014, Director at Phylos, Inc., Director at FeetMe SAS, Director at Stilla Technologies SA since 2018, Director at Novadiscovery SAS, and Venture Partner at LBO France Gestion SAS since 2018.
Former jobs include Chairman at NxStage Medical, Inc. from 1998 to 2013, Director at Transcend Therapeutics, Inc., Director at Nuvelo, Inc., Director at Pharsight Corp.
in 2007, Director at Kalypsys, Inc., Director at Auxilium Pharmaceuticals LLC from 2003 to 2011, Independent Director at Epocrates LLC from 2011 to 2013, Director at Aureon Biosciences, Inc., Director at Truveris, Inc., Director at Principia Biopharma, Inc., Director at Spotfire, Inc., Director at VaxInnate Corp., Director at Artisan Pharma, Inc., Executive Director-New Product Management at Sandoz Pharmaceuticals Corp.
in 1993, Independent Non-Executive Director at Pharnext SA in 2018, Director at Karos Pharmaceuticals, Inc., Director at Treato Ltd., Director at Tribun Health SAS, General Partner at Sprout Group from 1995 to 2004, and Manager-Healthcare Practice at The Boston Consulting Group, Inc. from 1993 to 1995.
Education includes an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Université Paris 1 Panthéon-Sorbonne.
Philippe Chambon active positions
| Companies | Position | Start |
|---|---|---|
BioRelix, Inc.
 BioRelix, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of antibiotics | Director/Board Member | 16/04/2009 |
Qpid Health, Inc.
 Qpid Health, Inc. Packaged SoftwareTechnology Services Provides health record acceleration software and intelligence solutions | Director/Board Member | 06/05/2014 |
Phylos, Inc.
 Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and manufacturing services | Director/Board Member | - |
LBO France Gestion SAS
 LBO France Gestion SAS Investment ManagersFinance LBO France is an active manager which invests in small- to medium-sized French or French-managed companies across a variety of sectors. The firm takes majority or controlling minority positions in companies valued between 10 million to 2.5 billion euros across manufacturing and services sectors, seeking to invest in profitable, market-leading businesses with growth potential. LBO France always takes a seat on the Supervisory Board of their investee companies, supporting management with strategic decisions and not interfering with day-to-day management. The firm invests in a limited number of companies, generally holding an investment for three to seven years, seeking to realize investments by finding a trade purchaser or arranging a secondary LBO or an IPO. For small-cap investments, LBO France focuses exclusively on unquoted companies with enterprise values of 10 to 50 million euros which have predictable revenue, profit and cash flows, excellent potential for growth or consolidation and a solid business plan offering good prospects for increasing valuation. For medium-sized firms with an enterprise value of 0.1 to 2.5 billion euros, the firm employs either a continuity or transformation strategy. Their continuity strategy utilizes leverage to acquire a majority stake in companies with predictable sales, profits and cash flow, a competitive cost structure or one that may be rapidly improved, a capable existing or potential management team and a strong market position and possible market leadership. Investee companies may be family-owned companies or subsidiaries or divisions of major groups. The firm's transformation strategy involves taking a majority or a minority position in companies with distinct and disposable business activities, under-utilized assets, substantial market share and a competitive advantage. They focus each company on their fastest-growing businesses and markets and sell their other businesses. They seek to increase operating margins by reducing costs, freeing up working capital and developing new business and set up management teams using performance-based remuneration to motivate them. LBO France's real estate team specializes in the French property sector, investing in all asset types and market segments including property companies, properties that generate capital gains (held from three to five years) and income properties (held for over five years). The firm's real estate team targets investments with asset values greater than 30 million euros. | Private Equity Investor | 01/02/2018 |
Stilla Technologies SA
 Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology and operates software application | Director/Board Member | 25/11/2018 |
Novadiscovery SAS
 Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Director/Board Member | - |
FeetMe SAS
 FeetMe SAS Electronic Equipment/InstrumentsElectronic Technology Develops smart connected insoles that can measure data and transfer wirelessly to a device | Director/Board Member | - |
Former positions of Philippe Chambon
| Companies | Position | End |
|---|---|---|
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Founder | 31/12/2018 |
| PHARNEXT SCA | Director/Board Member | 17/09/2018 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Philippe Chambon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
30
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 30 |
|---|---|
Transcend Therapeutics, Inc.
 Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Pharsight Corp.
 Pharsight Corp. Packaged SoftwareTechnology Services Develops computer-assisted trial design software | Technology Services |
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Epocrates LLC
 Epocrates LLC Medical SpecialtiesHealth Technology Provides clinical tools and solutions | Health Technology |
Aureon Biosciences, Inc.
 Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services | Health Technology |
BioRelix, Inc.
BioRelix, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of antibiotics | Health Technology |
Truveris, Inc.
 Truveris, Inc. Medical/Nursing ServicesHealth Services Provides health information technology services | Health Services |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Qpid Health, Inc.
Qpid Health, Inc. Packaged SoftwareTechnology Services Provides health record acceleration software and intelligence solutions | Technology Services |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout invest in companies located in North America. The firm focuses communications, software, services & e-commerce and healthcare technology sectors. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LBO France Gestion SAS
LBO France Gestion SAS Investment ManagersFinance LBO France is an active manager which invests in small- to medium-sized French or French-managed companies across a variety of sectors. The firm takes majority or controlling minority positions in companies valued between 10 million to 2.5 billion euros across manufacturing and services sectors, seeking to invest in profitable, market-leading businesses with growth potential. LBO France always takes a seat on the Supervisory Board of their investee companies, supporting management with strategic decisions and not interfering with day-to-day management. The firm invests in a limited number of companies, generally holding an investment for three to seven years, seeking to realize investments by finding a trade purchaser or arranging a secondary LBO or an IPO. For small-cap investments, LBO France focuses exclusively on unquoted companies with enterprise values of 10 to 50 million euros which have predictable revenue, profit and cash flows, excellent potential for growth or consolidation and a solid business plan offering good prospects for increasing valuation. For medium-sized firms with an enterprise value of 0.1 to 2.5 billion euros, the firm employs either a continuity or transformation strategy. Their continuity strategy utilizes leverage to acquire a majority stake in companies with predictable sales, profits and cash flow, a competitive cost structure or one that may be rapidly improved, a capable existing or potential management team and a strong market position and possible market leadership. Investee companies may be family-owned companies or subsidiaries or divisions of major groups. The firm's transformation strategy involves taking a majority or a minority position in companies with distinct and disposable business activities, under-utilized assets, substantial market share and a competitive advantage. They focus each company on their fastest-growing businesses and markets and sell their other businesses. They seek to increase operating margins by reducing costs, freeing up working capital and developing new business and set up management teams using performance-based remuneration to motivate them. LBO France's real estate team specializes in the French property sector, investing in all asset types and market segments including property companies, properties that generate capital gains (held from three to five years) and income properties (held for over five years). The firm's real estate team targets investments with asset values greater than 30 million euros. | Finance |
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and manufacturing services | Commercial Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
NxStage Medical, Inc.
 NxStage Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets products for the treatment of kidney failure and related diseases | Health Technology |
Spotfire, Inc.
 Spotfire, Inc. Packaged SoftwareTechnology Services Develops enterprise data analytics, business intelligence, data visualization and AI-powered analytics software | Technology Services |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Health Technology |
Artisan Pharma, Inc.
 Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Provides critical-care and hospital-based therapeutics to patients | Health Services |
Sandoz Pharmaceuticals Corp. | |
Pharnext SA
 Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Karos Pharmaceuticals, Inc.
 Karos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Treato Ltd.
 Treato Ltd. Packaged SoftwareTechnology Services Provides social health patient intelligence solutions | Technology Services |
FeetMe SAS
FeetMe SAS Electronic Equipment/InstrumentsElectronic Technology Develops smart connected insoles that can measure data and transfer wirelessly to a device | Electronic Technology |
Stilla Technologies SA
Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology and operates software application | Commercial Services |
Tribun Healthcare SAS
 Tribun Healthcare SAS Packaged SoftwareTechnology Services Develops software for digital pathology | Technology Services |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Technology Services |
- Stock Market
- Insiders
- Philippe Chambon
